APA

Wohl D. A., Kendall M. A., Owens S., Holland G., Nokta M., Spector S. A., Schrier R., Fiscus S., Davis M., Jacobson M. A., Currier J. S., Squires K., Alston-Smith B., Andersen J., Freeman W. R., Higgins M. & Torriani F. J. (20051110). The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. : HIV clinical trials.

Chicago

Wohl D A, Kendall M A, Owens S, Holland G, Nokta M, Spector S A, Schrier R, Fiscus S, Davis M, Jacobson M A, Currier J S, Squires K, Alston-Smith B, Andersen J, Freeman W R, Higgins M and Torriani F J. 20051110. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. : HIV clinical trials.

Harvard

Wohl D. A., Kendall M. A., Owens S., Holland G., Nokta M., Spector S. A., Schrier R., Fiscus S., Davis M., Jacobson M. A., Currier J. S., Squires K., Alston-Smith B., Andersen J., Freeman W. R., Higgins M. and Torriani F. J. (20051110). The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. : HIV clinical trials.

MLA

Wohl D A, Kendall M A, Owens S, Holland G, Nokta M, Spector S A, Schrier R, Fiscus S, Davis M, Jacobson M A, Currier J S, Squires K, Alston-Smith B, Andersen J, Freeman W R, Higgins M and Torriani F J. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. : HIV clinical trials. 20051110.